Dr. Leon Henderson-MacLennan of inThought Research discusses the evolving healthcare landscape and innovative approaches to decision making in healthcare.
In the latest episode of The Business of Pharmacy Podcast, Dr. Leon Henderson-MacLennan of inThought Research discusses strategies for navigating competitive intelligence in the pharmaceutical industry, offering insights into data analysis, market trends, and the importance of strategic planning. Learn how to stay ahead in a rapidly evolving market.
inThought Research’s Ben Weintraub and Doug Foster discuss how AI can help decision-making in pharma on Dr. Andree Bates’ latest podcast episode.
The panel discussed the decision-making process for one specific aspect of drug discovery – the choice to move forward with the development of a new drug compound. We discussed best practices for assembling a cross functional team and developing a concise rationale for a proposed plan, and we presented a framework for future decisions that align with company goals, curating and leveraging the knowledge that is needed to maintain good decisions.
The panel stressed the dynamic nature of decision-making in the pharmaceutical industry, the importance of continuous monitoring, and the need for effective knowledge management to support informed choices at every stage of drug development. Challenges include decision-making in different-sized organizations, resource availability, decision-making culture, and stakeholder preferences.
Listen to inThought Research’s Leon Henderson-MacLennan, MD, FACP on another episode of Raising Biotech’s podcast, this time a ‘trash to treasures’ biotech story.
inThought’s Leon Henderson-MacLennan, MD, FACP was a guest on the first episode of Raising Biotech, Surani Fernando’s podcast. Take a listen.
inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific expertise, and advanced AI analytics to navigate the complex landscape of drug development.
© 2024 inThought Research. All Rights Reserved.
As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.
With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.
Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.
